| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 138,794 | 107,825 | 125,385 | 108,782 | | Cost of Revenue | 75,750 | 56,437 | 69,129 | 66,279 | | | Gross Profit | 63,044 | 51,388 | 56,256 | 42,503 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,372 | 30,857 | 29,419 | 31,263 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,593 | 3,783 | 3,562 | 3,330 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 28,079 | 16,748 | 23,275 | 7,910 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,632 | (709) | (1,371) | (66) | | Earnings Before Interest And Taxes | 30,711 | 16,039 | 21,904 | 7,844 | | Interest Expense | 88 | 91 | 98 | 110 | | Income Before Tax | 30,623 | 15,948 | 21,806 | 7,734 | | Income Tax Expense | 10,749 | 5,626 | 8,220 | 2,460 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,874 | 10,322 | 13,586 | 5,274 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,874 | 10,322 | 13,586 | 5,274 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,874 | $10,322 | $13,586 | $5,274 |
|
0.01% Nasdaq 
0.22%
Income Statement
